CRCGN016_MCF10A.WT.HP_24H:F11 Gene Set
Genes
25 genes differentially expressed following the CRCGN016_MCF10A.WT.HP_24H:F11 small molecule perturbation from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
increased expression
| Symbol |
Name |
Standardized Value |
|
COMP
|
cartilage oligomeric matrix protein
|
4.41375
|
|
ACAA1
|
acetyl-CoA acyltransferase 1
|
3.94035
|
|
AGR2
|
anterior gradient 2
|
3.71517
|
|
SPAG4
|
sperm associated antigen 4
|
3.18246
|
|
ADO
|
2-aminoethanethiol (cysteamine) dioxygenase
|
2.93472
|
|
GET1
|
guided entry of tail-anchored proteins factor 1
|
2.847
|
|
AGL
|
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
|
2.6253
|
|
ANO10
|
anoctamin 10
|
2.60687
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
2.4599
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
2.36614
|
|
MYLK
|
myosin light chain kinase
|
2.27342
|
|
E2F2
|
E2F transcription factor 2
|
2.13015
|
|
CIAO3
|
cytosolic iron-sulfur assembly component 3
|
2.1107
|
|
WIF1
|
WNT inhibitory factor 1
|
2.06855
|
decreased expression
| Symbol |
Name |
Standardized Value |
|
HMG20B
|
high mobility group 20B
|
-7.02205
|
|
BASP1
|
brain abundant, membrane attached signal protein 1
|
-2.9026
|
|
NT5DC2
|
5'-nucleotidase domain containing 2
|
-2.73296
|
|
TENT4A
|
terminal nucleotidyltransferase 4A
|
-2.63279
|
|
DSG2
|
desmoglein 2
|
-2.59392
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
-2.55201
|
|
MFSD12
|
major facilitator superfamily domain containing 12
|
-2.43023
|
|
MT1X
|
metallothionein 1X
|
-2.41682
|
|
CBR3
|
carbonyl reductase 3
|
-2.19267
|
|
PIP5K1C
|
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma
|
-2.16627
|
|
PMM2
|
phosphomannomutase 2
|
-2.11492
|
